Aspiriant LLC’s iShares 5-10 Year Investment Grade Corporate Bond ETF IGIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-5,988
Closed -$327K 93
2014
Q4
$327K Sell
5,988
-2,542
-30% -$139K 0.04% 69
2014
Q3
$466K Buy
8,530
+32
+0.4% +$1.76K 0.07% 61
2014
Q2
$468K Buy
8,498
+34
+0.4% +$1.86K 0.06% 64
2014
Q1
$462K Buy
8,464
+36
+0.4% +$1.96K 0.07% 67
2013
Q4
$455K Buy
+8,428
New +$456K 0.07% 58
2013
Q3
Sell
-8,194
Closed -$441K 55
2013
Q2
$441K Buy
+8,194
New +$452K 0.07% 47

Other funds holding IGIB

Aspiriant LLC's IGIB Position: Q1 2015 in Review

Aspiriant LLC sold out of iShares 5-10 Year Investment Grade Corporate Bond ETF (IGIB) in Q1 2015, closing a stake of 5,988 shares — an estimated $327K sold.

Aspiriant LLC first reported a position in IGIB in Q2 2013 and held it in 6 quarters. The position peaked at $468K in Q2 2014. 253 funds tracked by Wall St. Rank hold IGIB as of Q1 2015.

  • Aspiriant LLC reported no remaining iShares 5-10 Year Investment Grade Corporate Bond ETF position as of Q1 2015 after selling out during the quarter.
  • Aspiriant LLC sold 5,988 iShares 5-10 Year Investment Grade Corporate Bond ETF shares in Q1 2015, an estimated $327K.
  • Aspiriant LLC first reported a position in iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2013 and held it in 6 quarters.
  • Aspiriant LLC's iShares 5-10 Year Investment Grade Corporate Bond ETF position peaked at $468K in Q2 2014.
  • 253 funds tracked by Wall St. Rank held iShares 5-10 Year Investment Grade Corporate Bond ETF as of Q1 2015.

Based on Aspiriant LLC's 13F filing for Q1 2015, filed 8 May 2015.